Related content

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

By Boelaert Jente   Schepers Eva   Glorieux Griet   Eloot Sunny   Vanholder Raymond   Lynen Frédéric  

Toxins, Vol. 8, Iss. 11, 2016-10 ,pp. : 312-312

MDPI

Access to resources Recommend Favorite

Development and Validation of a UPLC-MS/MS and UPLC-HR-MS Method for the Determination of Fumonisin B1 and Its Hydrolysed Metabolites and Fumonisin B2 in Broiler Chicken Plasma

By De Baere Siegrid   Croubels Siska   Novak Barbara   Bichl Gerlinde   Antonissen Gunther  

Toxins, Vol. 10, Iss. 2, 2018-01 ,pp. : 62-62

MDPI

Access to resources Recommend Favorite

Pharmacokinetics of Dibutyl Phthalate (DBP) in the Rat Determined by UPLC-MS/MS

By Chang Li-Wen   Hou Mei-Ling   Tsai Tung-Hu  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 836-849

MDPI

Access to resources Recommend Favorite

Development and Validation of an UPLC-MS/MS Method for Pharmacokinetic Comparison of Five Alkaloids from JinQi Jiangtang Tablets and Its Monarch Drug Coptidis Rhizoma

By Sun Lili   Ding Feifei   You Guangjiao   Liu Han   Wang Meng   Ren Xiaoliang   Deng Yanru  

Pharmaceutics, Vol. 10, Iss. 1, 2017-12 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study

By Kruszelnicka Olga   Świerszcz Jolanta   Bednarek Jacek   Chyrchel Bernadeta   Surdacki Andrzej   Nessler Jadwiga  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 454-454

MDPI

Access to resources Recommend Favorite